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Background: The frequency of pregnancy-associated malaria is increasingly being documented in American
countries. In Colombia, with higher frequency of Plasmodium vivax over Plasmodium falciparum infection, recent
reports confirmed gestational malaria as a serious public health problem. Thick smear examination is the gold
standard to diagnose malaria in endemic settings, but in recent years, molecular diagnostic methods have
contributed to elucidate the dimension of the problem of gestational malaria. The study was aimed at exploring
the prevalence of gestational, placental and congenital malaria in women who delivered at the local hospitals of
north-west Colombia, between June 2008 and April 2011.
Methods: A group of 129 parturient women was selected to explore the prevalence of gestational, placental and
congenital malaria in a descriptive, prospective and transversal (prevalence) design. Diagnosis was based on the
simultaneous application of two independent diagnostic tests: microscopy of thick blood smears and a polymerase
chain reaction assay (PCR).
Results: The prevalence of gestational malaria (thick smear /PCR) was 9.1%/14.0%; placental malaria was 3.3%/16.5%
and congenital malaria was absent. A history of gestational malaria during the current pregnancy was significantly
associated with gestational malaria at delivery. Plasmodium vivax caused 65% of cases of gestational malaria,
whereas P. falciparum caused most cases of placental malaria.
Conclusions: Gestational and placental malaria are a serious problem in the region, but the risk of congenital
malaria is low. A history of malaria during pregnancy may be a practical indicator of infection at delivery.
Keywords: Pregnancy, Malaria, Plasmodium, Prevalence, ColombiaBackground
Women inhabiting malaria endemic areas are at variable
risk of acquiring gestational malaria according to the de-
gree of endemicity and their parity. In regions of high
stable transmission, they might acquire significant cli-
nical immunity before pregnancy, and placental malaria
is often asymptomatic, but it can produce severe mater-
nal anaemia and foetal growth restriction [1]. In such
regions, placental malaria is common in first-time
mothers, and women develop specific immunity against
placental infection over successive pregnancies. On the
other hand, in areas of low unstable transmission, mal-
aria is often symptomatic, regardless of parity, and it
might result in foetal loss and maternal death [2].* Correspondence: aemaestre@gmail.com
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reproduction in any medium, provided the orIn the Americas, the problem of gestational malaria
has been the subject of few reports [3-6]. The frequency
of gestational malaria and placental malaria in the region
of Uraba, north-west Colombia, is relatively high, affect-
ing 10–12 out of 100 pregnant women, when measured
by microscopy [7]. A report based on samples from the
same region (2004–2006) found a prevalence of ges-
tational malaria of 14.0% and placental malaria of 10.5%
(by thick smear microscopy) [8]. Another study on
Plasmodium infection at the time of delivery, reported a
prevalence of gestational malaria of 13% with micros-
copy, but the frequency increased to 32% with a poly-
merase chain reaction (PCR) assay [9]. In addition, the
histopathological examination of placental tissue showed
unmistakable signs of placental malaria in 19% of the 79
specimens studied, in which 33% were characterized as
acute, 7% as chronic and 60% as past infections [9]. Thel Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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that of microscopy and PCR, mainly because the basis of
the histopathology diagnosis is the observation of the
parasite and/or the malarial pigment.
Recent evidence gathered in the country, confirmed
the deleterious effect of the infection, in both P. vivax
and P. falciparum malaria, in pregnant subjects, with
presence of organ specific complications [10], congeni-
tal malaria [11], and low birth weight and prematurity
[12]. All the above data confirmed gestational and pla-
cental malaria as a serious public health problem in
north-west Colombia, where most of the country´s
cases of malaria are reported. In addition, these reports
confirmed that both P. falciparum and P. vivax are the
causative species in these conditions, with 65-70% of
reported cases due to P. vivax [13,14].
Resistance of P. falciparum to anti-malarials is wide-
spread in the country [15,16], and artemisinin-based
combination therapy is recommended from 2006, with
two different schemes applied between 2006–2009:
a three-day course of artesunate plus mefloquine for
the Antioquia department and a three-day course of
artemether plus lumefantrine for the Cordoba depart-
ment. As for gestational malaria, women in their 2nd
and 3rd trimester of pregnancy were treated as non-
pregnant subjects according to the place of residency,
or with a 7- day course of quinine plus clindamycin if
on their 1st trimester of pregancy. In 2009, the scheme
artesunate plus mefloquine was withdrawn as first-line
from the national treatment guidelines and artemether
plus lumefantrine is used throughout the country.
Vivax malaria remains sensitive to a three-day course
of chloroquine [17] and, in non-pregnant subjects, is
administered in combination with a 14-day course of
primaquine [18].
A study carried out in three municipalities of the
Uraba region (north-west Colombia) recruited and
followed >2,000 pregnant women at the antenatal
clinics and hospitals to obtain a measure of incidenced
from a group of 250 pregnant women recruited at de-
livery. Two studies explored the prevalence of gesta-
tional malaria and placental malaria at delivery in the
Uraba region [8,9], yet no data are available from the
Cordoba region, which, together with Uraba and Bajo
Cauca, constitute the majority of malaria cases in
Colombia [13,14].
The current study reports on the results of a study
aimed at exploring the prevalence of gestational, pla-
cental and congenital malaria in women who deli-
vered at the local hospitals of north-west Colombia,
between June 2008 and April 2011. Diagnosis was
based on the simultaneous application of two inde-
pendent diagnostic tests: microscopy of thick blood
smear and a PCR.Methods
Study area
The study was carried out in north-west Colombia in the
localities of Turbo (Antioquia department) and Puerto
Libertador (Cordoba department) (Figure 1). Between
Antioquia and Cordoba lays the malaria endemic region
known as Uraba-Altos Sinu/San Jorge-Bajo Cauca, which
has an estimated area of 43,506 km2 and a malaria at-risk
population of 2.5 million distributed in 35 municipalities.
The Antioquia department reported 20,511 (in 2008),
32,029 (in 2009) and 45,618 (in 2010) cases of malaria
[19]. Plasmodium vivax was reported in 65–70% of total
cases. Meanwhile, in Cordoba, during 2001–2009, in
1,433,461 inhabitants, a mean number of 37,616 cases/
year were reported: 69% caused by P. vivax, 23% by P.
falciparum and 1% from mixed infection. The municipal-
ities of Valencia and Tierralta (south-west Cordoba, on
the border with Uraba), and Puerto Libertador (south-east
Cordoba) reported 90% of malaria cases in the region [20].
Subjects for the current study were recruited at the
local hospitals “ESE Hospital Francisco Valderrama”, in
Turbo, and “CAMU Divino Niño”, in Puerto Libertador.
In these localities, the annual mean parasitic indexes
(malaria cases/1000 inhabitants) during 2000–2009 were
46.6 in Turbo and 23.4 in Puerto Libertador [19,20].
Study design and sample selection
The study was part of a larger project aimed at exploring
the epidemiology (incidence and prevalence measures),
clinical aspects (mother and child outcomes), and im-
munopathology (placental damage and immune regula-
tion secondary to infection) of gestational and placental
malaria in north-west Colombia, partial results have
been reported on the frequency of infection and the
histopathology of placental malaria [7,9,21]. A total
2,000 pregnant women were recruited for the main
study at the localities of Turbo and Puerto Libertador.
Subjects were recruited in a sequential fashion until the
sample size for the main study was reached. Clinical and
epidemiological surveys were applied to all those
women. Data from medical records were also obtained
in order to assess the clinical outcome of the pregnancy.
A subset of subjects was selected to explore the preva-
lence of the conditions in a descriptive, prospective and
transversal (prevalence) design. A sample size of 129
pregnant women was calculated based on the following
parameters: a total of 2,000 in-hospital deliveries during
the 34 months of the study; 10% expected frequency of
malaria (gestational malaria or placental malaria); 95%
confidence interval; 5% sampling error. Subjects were se-
lected and included in this study using a simple random
sampling method from the records of the 2,000 women
recruited in the main project. The prevalence of infec-
tion by Plasmodium was assessed intra-partum using
Figure 1 Map of Colombia. Turbo (Uraba region) of Antioquia department and Puerto Libertador (Cordoba) where the study took place, are
located in north-west Colombia.
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PCR. For this, paired blood samples were obtained
from peripheral vein of the mother and from the pla-
centa at time of delivery.
Inclusion and exclusion criteria
Inclusion criteria were > 1 year residency in the study re-
gion, general good health and no history of serious dis-
ease, signature of the voluntary consent form and
hospital delivery. The only exclusion criterion was with-
drawal of the voluntary consent.
Term definitions
The following definitions were applied: A) Low birth
weight: <2,500 grams. B) Premature neonate: <37 weeks. C)
Intra-uterine growth restriction: ≥37 weeks of gestation and
low birth weight. D) Abortion: delivery before 22 weeks ofpregnancy. E) Stillbirth: dead neonate of >22 weeks. F)
Anaemia: haemoglobin <11 g/dL. G) Full term preg-
nancy: >38 weeks. H) Gestational or pregnancy malaria:
plasmodial infection diagnosed in a pregnant woman
after examination of maternal peripheral blood. I) Pla-
cental malaria: plasmodial infection diagnosed in pla-
centa after examination of placental blood.
Sample preparation
Whole blood samples from mother´s peripheral blood
and placenta were obtained at delivery rooms in the
local hospitals of Puerto Libertador and Turbo. The
mother`s sample was obtained by finger prick and pla-
cental blood was obtained from the lake formed fol-
lowing a wash with saline (0.9%) and removal of a 3x3x3
cm section in the area of the cord’s insertion on the ma-
ternal side of the organ. These samples were used to
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detailed below.
Diagnosis of Plasmodium infection
The presence of Plasmodium was confirmed in mater-
nal, placental and cord blood by thick smear and a
nested PCR according to standard published methods
[9,22,23]. Diagnosis by microscopy was carried out in
the field site by a trained technician with certified ex-
perience in malaria diagnosis. Parasitaemia was calcu-
lated after observation of fields corresponding to 200
leukocytes and a constant of 8,000 leucocytes/μL. A
sample was considered negative after observation of 500
high power fields.
Diagnosis of infection by PCR was performed to whole
blood samples collected onto Whatman 3MM filter
paper, from which DNA was extracted using Chelex100®
(Sigma™). Amplification was carried out using a nested
PCR assay to detect the 18 s rRNA gene of P. falciparum
and P. vivax, according to previously published proce-
dures [23]. Positive reaction controls consisted of DNA
from the laboratory-adapted strain P. falciparum 3D7
and from a well characterized field isolate of P. vivax.
Amplification products were resolved in a 2% agarose
gel using ethidium bromide and visualized under UV
light. Samples were processed once as long as controls
were confirmed to operate in optimal conditions, other-
wise, the assay was repeated until successful perfor-
mance of controls.
Statistical analyses
The prevalence of gestational malaria and placental malaria
was calculated according to the results of thick smear mi-
croscopy and PCR. The association between the distribu-
tion of frequencies among two variables was identified
using χ2. Significance was established at p < 0.05%. Data
analyses were performed using EpiInfo® 6.0 and SPSS® 10.0.
Ethical aspects
The study protocol was reviewed and approved by:
a) Ethics Committee of the Sede de Investigaciones
Universitarias SIU, Universidad de Antioquia (Medellín,
Colombia) (acta 07-32-126: project Colciencias code
111540820495, contract: 238–2007); b) Ethics Com-
mittee of the Instituto de Investigaciones Medicas,
Universidad de Antioquia (acta 012: project Colciencias
code 111549326134, contract 611 de 2009); c) Ethics
Committee of Instituto de Investigaciones Medicas,
Universidad de Antioquia (Medellin, Colombia) (project
Regionalización-Universidad de Antioquia IIM 8764–
2530). Each participant gave full informed consent
according to the Helsinki convention and the Colom-
bian regulations for this type of research. Each subject
voluntarily accepted to participate in the study.Women with a positive peripheral blood thick smear
were treated, before hospital discharge, according to the
recommendation of the Ministry of Health: a three-day
course of chloroquine (25 mg/kg total dose) plus a 14-day
course of primaquine (0.25 mg/kg/day) in P. vivax infec-
tion, or, in P. falciparum, a 3-day course of artesunate plus
mefloquine at 200 mg and 500 mg, respectively, per day in
subjects aged >13 years (Antioquia department) or
artemether plus lumefantrine (Coartem®) twice a day
for a total six doses in subjects >34 kg (Cordoba de-
partment) [18].
Results
During the 34 months of the study (June 2008 - April
2011), a total of 121 parturient women were recruited at
the local hospitals (eight records, out of the 129
expected subjects, had incomplete information). In ge-
neral, subjects were young (mean age = 21.9 ± 6.7), the
mean number of gravidity, including the current preg-
nancy, was 3.2 ± 2.9; all (but one) had a full term preg-
nancy (38.8 ± 2.1 weeks), and their mean haemoglobin
level was 10.6 ± 0.13 g/dL (mean 10.3 g/dL in thick
smear-gestational malaria positive and mean10.6 g/dL in
thick smear-gestational malaria negative, p >0.05). Re-
view of clinical records confirmed that attendance to the
antenatal clinic was late, scarce and irregular with a
mean number of clinical evaluations of three and < 20%
of mothers receiving > 5 evaluations. In addition, appli-
cation of a VDRL test during the antenatal period was
performed in 70 subjects and one woman tested positive
(titer 1:8). A total of 48 subjects were tested for HIV and
all were negative. All participants were asymptomatic for
malaria infection at delivery, and insecticide-treated nets
were not used.
The frequency of gestational malaria was 9.1% (11/121)
by microscopy, and 14.0% (17/121) by PCR (Table 1).
Meanwhile, the frequency of placental malaria was 3.3%
(4/121) by microscopy and 16.5% (20/121) by PCR. In
cases of gestational malaria, the frequency of submicro-
scopic parasitaemia (i.e. a positive PCR with negative mi-
croscopy) was 4.9% (14.0–9.1), and in cases of placental
malaria this was 13.2% (16.5–3.3). The ratio between posi-
tive microscopy and positive PCR in gestational malaria
was 1:1.5, and in placental malaria this was 1:5.
Among the 17 cases of gestational malaria diagnosed
by PCR, 65% (11/17) were P. vivax, and 35% (6/17)
were P. falciparum. The opposite was observed in pla-
cental malaria: P. falciparum was detected in 65% (13/
20), and P. vivax in 35% (7/20) of cases. All samples of
umbilical cord blood were negative for malarial para-
sites by both tests.
Concurrence of gestational and placental malaria by
microscopy was absent in the 110 subjects negative by
microscopy and 36% of the 11 subjects with gestational
Table 1 Comparison of frequencies of gestational and




Negative P. vivax P. falciparum Total
Microscopy
Negative 103 4 3 110
P vivax 0 7 0 7
P falciparum 1 0 2 3
Mixed 0 0 1 1
Total 104 11 6 121
B. Placental Malaria
PCR
Negative P. vivax P. falciparum Total
Microscopy
Negative 101 5 11 117
P vivax 0 2 0 2
P falciparum 0 0 2 2
Total 101 7 13 121
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simultaneous maternal and placental infection increased
when PCR was performed: in the 104 gestational malaria
negative subjects, 92% (96/104) were placental malaria
free, and in the 17 gestational malaria positive subjects,
71% (12/17) exhibited placental malaria. Therefore, the
presence of parasites in the peripheral mother`s bloodTable 2 Correlation between diagnosis of gestational malaria
(A. Thick smear microscopy and B. PCR)
















Total 101was not always associated with placental infection, but
absence of parasites in the mother`s blood did not ne-
cessarily imply that the placenta was free of infection
(Table 2).
History of gestational malaria was confirmed by review
of clinical records in 26% (31/120); cases were diagnosed
by microscopy of mother´s peripheral blood and were
treated according to the Ministry of Health guidelines
for malaria in pregnancy by the time of diagnosis and as
detailed in the introduction section. In 87% (27/31) of
cases of gestational malaria before delivery, at least one
of the following was recorded: Plasmodium species,
parasitaemia, or the gestational age at the time of diag-
nosis. When species was recorded (18/27 or 67%), 78%
corresponded to P. vivax, and the remaining were P.
falciparum. The mean parasitaemia in P. falciparum in-
fections was 2,771 ± 4,876 parasites/μL (median: 617;
range: 40--18.060).
Intrapartum microscopy or PCR of peripheral blood
confirmed infection in up to 35.5% (11/31) of the sub-
jects with a history of gestational malaria (73% P. vivax,
18% P. falciparum, 9% mixed). In the 89 mothers with-
out a history of gestational malaria, infection was de-
tected at delivery in 7% (3.5% each P. vivax and P.
falciparum). A report of gestational malaria in the
current pregnancy was significantly associated (p =
0.000121) with a positive PCR test at delivery and 94%
(84/89) of the women without a history of malaria were
negative for gestational malaria at delivery (Table 3).
According the place of residency, prevalence of gesta-
tional malaria was 4% (3/71) in Turbo and 28% in Puertoand placental malaria by two diagnostic methods











Table 3 Correlation of diagnosis of gestational or
placental malaria at delivery by PCR and a history of
gestational malaria during pregnancy
A. Gestational malaria*
Negative P. vivax P. falciparum Total
History of gestational
malaria
Negative 84 3 2 89
Positive 20 8 3 31
Total 104 11 5 120
B. Placental malaria+
Negative P. vivax P. falciparum Total
History of gestational
malaria
Negative 83 1 5 89
Positive 18 6 7 31
Total 101 7 12 120
*p = 0.000121 for species, p = 0.000094 for presence-absence of infection,
+p = 0.000010 for species and p = 0.000014 for presence-absence of infection.
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malaria was 4% (3/71) and 34% (17/50), respectively.
Therefore, both gestational and placental malaria were sig-
nificantly associated to the place of residency (p =
0.001040 and p = 0.000049, respectively) (Table 4). No sig-
nificant association could be confirmed between parity
and presence of malarial infection by any of the tests ap-
plied (p > 0.153), which means that regardless of being in
their first, second, third or >3rd pregnancy, all women had
the same risk of gestational malaria and placental malaria.
In one subject a stillbirth was reported. This occurred
in an 18 year-old mother in her first pregnancy and with
a history of gestational malaria by P. vivax. Maternal
haemoglobin at delivery was 9.1 g/dL and the gestational
age was 27 weeks. Malaria-specific results for this caseTable 4 Frequencies of diagnosis of gestational and
placental malaria at delivery by PCR according to locality
A. Gestational malaria*
Negative P. vivax P. falciparum Total
Turbo 68 2 1 71
Puerto Libertador 36 9 5 50
Total 104 11 6 121
B. Placental malaria+
Negative P. vivax P. falciparum Total
Turbo 68 0 3 71
Puerto Libertador 33 7 10 50
Total 101 7 13 121
*p = 0.001040 for species, p = 0.000211 for presence-absence of infection,
+p = 0.000049 for species and p = 0.000014 for presence-absence of infection.confirmed maternal infection with P. vivax and P. falcip-
arum by microscopy whereas only P. falciparum was
detected by PCR. Placental infection by P. falciparum
was detected by both tests and the cord blood was nega-
tive for infection.
Discussion
The current report on the prevalence of gestational, pla-
cental and congenital malaria in parturient women from
a highly malaria endemic region of Colombia, further
defines the epidemiology of this infection in the country.
A major limitation of the study is the absence of follow-
up at the antenatal clinic and the recruitment in a
passive fashion. This resulted in the inclusion of a popu-
lation which might not precisely reflect the dimension of
the malaria problem during pregnancy. Nevertheless, the
fact that all studied subjects were asymptomatic for mal-
aria, suggests that the figures herein published under-
estimate the actual frequency of gestational malaria.
Current ongoing studies, overcome this limitation by
including recruitment at the antenatal clinics and
follow-up until delivery.
It is important to highlight that during the recruitment
of subjects for the current study, the health authorities of
Uraba carried out an intense malaria control programme
from 2007 until 2009 with a major impact on the fre-
quency of malaria, as reported herein. The programme,
named “Papa Luis”, consisted of massive anti-malarial ad-
ministration (chloroquine), biologic control of Anopheles
spp. larvae, swamp drainage and indoor residual spraying.
A programme as such was not implemented in Cor-
doba. In addition, both study regions were deeply af-
fected by intense and continuous rainy seasons during
2008, 2010 and the first six months of 2011, which also
contributed to a reduction in the reported number of
cases concomitantly with the rains, followed by a rise of
cases as they decline. Finally, attendance of mothers at
any health facility was seriously affected by the political
instability and social insecurity prevalent in the region.
All these factors contributed to reduced attendance at
hospitals, increased the recruitment period and, very
probably, impacted the results after inclusion of sub-
jects resident in and around urban centers. Neverthe-
less, in Puerto Libertador the frequency of gestational
malaria was seven times that recorded in Turbo (4% vs.
28%) and placental malaria was eight-fold that observed
in Turbo (4% vs. 34%). Climate conditions and turmoil
from violence are similar in both regions and only the
application of control programmes seems to differ be-
tween the two localities. Major fluctuations in the fre-
quency of gestational and pregnant malaria have also
been reported in other endemic countries [24,25].
Studies on gestational placental or congenital malaria
are scarce in America in comparison to Africa [4-6,26,27]
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and Brazil [4,26]. In the Brazilian Amazon, among 1,699
women with malaria, the prevalence of gestational malaria
was 11.7% and P. vivax was confirmed in 83% of cases
[25]. In a previous report from Rio Branco (Brazil) among
33,420 women who attended the hospital, 445 had gesta-
tional malaria resulting in a prevalence of 1.4%; P. vivax
was detected in 53% of them [24]. In the current report,
the prevalence of gestational malaria was 9.1% by micros-
copy and 14% by PCR, while the prevalence of placental
malaria was 3.3% by microscopy and 16.5% by PCR. The
positivity rates by microscopy, for the both gestational
and placental malaria, are lower than those previously
reported in 2004–2006 in the same region (10-14% ges-
tational malaria and 9-12% placental malaria) [7-9],
probably as a result of the intervention measures and
the climate conditions above detailed.
As for congenital malaria, the current report con-
firmed previous observations made by other authors on
the low frequency of infection in cord blood (2.5%) in
relation with higher rates of gestational malaria (9.5%)
[11]. Several factors might explain the relative protection
of the foetus to acquisition of congenital malaria, namely
the degree of previously acquired immunity of the
mother [28], the proportion of foetal haemoglobin [28],
and the higher frequency of P. vivax infection, which in
theory, fails to sequester in placenta, among others. The
fact that subjects recruited in this study were asymptom-
atic yet they presented with parasitaemia, strengthens
the important role of passive transfer of maternal anti-
malarial antibodies in the protection against congenital
malaria. This subject is under exploration in specifically-
designed ongoing studies.
Attendance to the antenatal clinic was inadequate in co-
incidence with previous reports from the region [7], and
the number of women tested for infections such as syphilis
and HIV was alarmingly low. Insecticide-treated net usage
is uncommon in Colombia (< 20%), as is indoor residual
spraying [29]. A similar situation is seen in other countries
of the Americas. The complete failure to use insecticide-
treated nets by subjects enrolled in this study, reflects the
lack of government will to effectively address the malaria
problem. Furthermore, intermittent preventive therapy
during pregnancy is not applied on a routine basis in
Colombia or elsewhere in the Americas, despite being a
proven control measure in most African countries [30].
Failure to apply any of the above-mentioned control mea-
sures, in addition to the lack of access to adequate ante-
natal care, the precarious life conditions and the extreme
political violence of most malaria endemic regions per-
petuate the high risk of malaria transmission, among other
infectious conditions, in mothers and their children.
The results reported herein confirm the higher fre-
quency of gestational and placental malaria detected byPCR compared to microscopy as reported previously in
this and other endemic regions [9,31,32]. Furthermore,
recent studies in Colombia confirm the higher sensitivity
of a quantitative PCR over a standard nested PCR, to de-
tect gestational and placental malaria [33]. However, in
field conditions, application of any molecular based ap-
proach remains impractical and innovative solutions are
highly welcomed by field researchers. Molecular tools
allow identification of sub-microscopic infections, which
in the current studied represented 4.9% of gestational
malaria and 13.2% of placental malaria, but no effect on
newborn`s weight or mother’s haemoglobin could be
confirmed. A recent review on submicroscopic Plasmo-
dium infection during pregnancy concluded that the risk
of anaemia and low birth weight infants are increased in
positive cases [34]. Following up studies, with precise as-
sessment of clinical outcomes in infected cases might
help to elucidate the consequences of submicroscopic
malaria during pregnancy in this region of the continent.
The presence of a positive peripheral thick smear at
delivery seems insufficient to predict the existence of
placental infection, but a negative smear cannot guaran-
tee an uninfected placenta. Therefore, due to the poten-
tial risk of malaria in the mother, clinicians should
presume placental infection in all cases of gestational
malaria. Of major importance in the clinical practice is
the finding that a positive history of gestational malaria
correlated with gestational and/or placental malaria at
delivery, regardless of adequate anti-malarial treatment
of the original episode. Since P. falciparum seems to re-
main susceptible to artemisinin-based combination the-
rapy [35], possible explanations for placental parasite
persistence include sequestration of parasites in the
placenta, P. vivax relapses and erroneous species iden-
tification (a documented limitation of microscopy) du-
ring the primary episode.
The current report confirms the findings of previous
researchers which report gestational and placental mal-
aria as serious public health problems in north-west
Colombia. Moreover, during the period of study, the
local health authorities failed to observe the official rec-
ommendation since routine thick smear of peripheral
blood was not practiced at antenatal visits, delaying
diagnosis and treatment. This, combined with the social
inequity faced by the women and families inhabiting the
region; and the particular cultural frame and living con-
ditions, contributes to perpetuate the problem [36,37].
Malaria in Colombia is a disease of deprived and eco-
nomically unstable populations, which are also poorly
attended by the health services. Among them, women
are the most vulnerable from the social perspective since
they are particularly susceptible to develop malaria com-
plications during pregnancy and lack access to economic
and health resources [38-40].
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The following conclusions were reached: 1) the problem
of malaria during pregnancy and placental malaria is ser-
ious in north-west Colombia; 2) the history of gesta-
tional malaria constitutes an indicator of gestational and
placental malaria at delivery; 3) the risk of congenital
malaria is low; 4) measures should be implemented by
regional and national health authorities to guarantee that
recommendations regarding malaria testing at the ante-
natal clinics are fulfilled.
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